SIG
50
-5
GME
70
2
EXPE
93
2
ADBE
61
11
MMM
42
5
PCG
93
4
AMGN
31
-16
EFX
41
-5
EXPD
48
-5
NWSA
63
-4
TAP
63
2
OXY
37
-3
XOM
40
-7
C
62
-3
OKE
78
3
MPC
44
3
AAL
51
-3
BF.B
33
-4
AMG
57
2
KLAC
53
-3
SIG
50
-5
GME
70
2
EXPE
93
2
ADBE
61
11
MMM
42
5
PCG
93
4
AMGN
31
-16
EFX
41
-5
EXPD
48
-5
NWSA
63
-4
TAP
63
2
OXY
37
-3
XOM
40
-7
C
62
-3
OKE
78
3
MPC
44
3
AAL
51
-3
BF.B
33
-4
AMG
57
2
KLAC
53
-3
Financhill
Back

Biodexa Pharmaceuticals PLC 10K Form

Sell
20

BDRX
Biodexa Pharmaceuticals PLC

Last Price:
4.85
Seasonality Move:
-23.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BDRX News And Ratings

See the #1 stock for the next 7 days that we like better than BDRX

BDRX Financial Statistics

Sales & Book Value

Annual Sales: $474.09K
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $30.44
Price / Book: 0.25

Profitability

EPS (TTM): -74.59720
Net Income (TTM): $-8.53M
Gross Margin: $-4.59M
Return on Equity: 0%
Return on Assets: 0%

Biodexa Pharmaceuticals PLC Earnings Forecast

Key Biodexa Pharmaceuticals PLC Financial Ratios

  • The Gross Profit Margin over the past 11 years for BDRX is -967.45%.
  • The Selling, General & Administrative Expenses for BDRX have been equal to 1,139.63% of Gross Profit Margin.
  • The Interest Expense is -0.58% of Operating Income.
  • The Net Earning history of BDRX is -1,857.99% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 6 years.

Biodexa Pharmaceuticals PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BDRX
Website: biodexapharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BDRX Technical Analysis vs Fundamental Analysis

Sell
20
Biodexa Pharmaceuticals PLC (BDRX) is a Sell

Is Biodexa Pharmaceuticals PLC a Buy or a Sell?